Exploring the mechanism of kaji-ichigoside F1 on bacterial pneumonia based on the network pharmacology and transcriptome
Abstract
ObjectiveTo explore the anti-inflammatory mechanism of kaji-ichigoside F1 against bacterial pneumonia based on transcriptomics and network pharmacology. MethodNetwork pharmacological was used to analyse the potential target genes of kaji-ichigoside F1 action on bacterial pneumonia; molecular docking was used to analyse the docking binding energy of kaji-ichigoside F1 with key target genes; RAW264.7 macrophages were treated with klebsiella pneumoniae fluid and given kaji-ichigoside F1 intervention, the expression of inflammatory factors IL-1{beta}, IL-6, TNF- and IL-10 were dectected by qRT-PCR; transcriptomic analysis was performed to obtain differentially expressed genes, and relevant signaling pathways. ResultNetwork pharmacological analysis showed that the five the key target genes for kaji-ichigoside F1-bacterial pneumonia interaction were were TLR4, NFKB1, STAT3, IL1B, and JUN; molecular docking results of kaji-ichigoside F1 with key target genes showed the docking binding energy ranging from -5.9 to -8.4 kcal/mol; kaji-ichigoside F1 can reduce the klebsiella pneumoniae induced inflammatory response of macrophages, manifested with reducing the mRNA expression of pro-inflammatory factors IL-1{beta}, IL-6 and TNF-, and increase the mRNA expression of anti-inflammatory factor IL-10; transcriptomics analysis showed that the signaling pathways involved were mainly the TLR signaling pathway and NFKB signaling pathway. ConclusionThis study showed that kaji-ichigoside F1 alleviates bacterial pneumonia by targeting TLR and NFKB signaling pathways, rebalancing macrophage polarization with suppressing pro-inflammatory cytokines and increasing anti-inflammatory cytokines, highlighting kaji-ichigoside F1 as a novel agent for combating bacterial infections. Graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=144 SRC="FIGDIR/small/649383v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@7c96eorg.highwire.dtl.DTLVardef@13977a6org.highwire.dtl.DTLVardef@1de6214org.highwire.dtl.DTLVardef@f91c50_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Biofilm of Klebsiella pneumoniae minimize phagocytosis and cytokine expression by macrophage cell line
S. S. Rathore, L. Cheepurupalli, … J. Ramakrishnan·bioRxiv·Apr 30, 2019
- NF-kB-Dependent Transcriptional Regulation of Piezo1 Mediates Bacterial Clearance on Stiffened Lung
Erica M. Orsini, Adam M. Boulton, … Rachel Greenberg Scheraga·bioRxiv·Nov 6, 2025
- A Novel Role for the Nuclear Receptor, NR4A1, in Klebsiella pneumoniae Lung Infection
J. Partyka, M. Henkel, B. T. Campfield·bioRxiv·Sep 3, 2020
- Follistatin-like 1 Promotes Neutrophil-mediated Host Defense against Klebsiella pneumoniae
Norie Sugitani, Matthew Henkel, … Brian T. Campfield·bioRxiv·Nov 1, 2026
- Peucedanol ameliorates LPS-induced inflammation in RAW264.7 cells and CLP-induced sepsis in mice by inhibiting TLR4/myD88/NF-κB pathway
Qi Yao, Bo‐tao Chang·bioRxiv·Aug 2, 2024
- TNF licenses macrophages to undergo rapid caspase-1, -11, and -8-mediated cell death that restricts Legionella pneumophila infection
T. Y. Pollock, V. R. Vazquez Marrero, … S. Shin·bioRxiv·Jul 29, 2022